Takeda Pharmaceutical Co Ltd
XHAM:TKD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
Takeda Pharmaceutical Co Ltd
XHAM:TKD
|
JP |
|
R
|
Realtech AG
XMUN:RTC
|
DE |
|
Blackline Inc
NASDAQ:BL
|
US |
|
Eastern Bankshares Inc
F:EB0
|
US |
|
A
|
Alaska Air Group Inc
F:ALK
|
US |
|
A
|
Asia Sermkij Leasing PCL
SET:ASK
|
TH |
|
D
|
Dharma Polimetal Tbk PT
IDX:DRMA
|
ID |
|
T
|
Takeda Pharmaceutical Co Ltd
OTC:TKPHF
|
JP |
|
Universal Display Corp
NASDAQ:OLED
|
US |
|
S
|
Shell PLC
AEX:SHELL
|
UK |
|
T
|
Takeda Pharmaceutical Co Ltd
DUS:TKD
|
JP |
Wall St Price Targets
TKD Price Targets Summary
Takeda Pharmaceutical Co Ltd
According to Wall Street analysts, the average 1-year price target for TKD is 33.96 EUR with a low forecast of 28.24 EUR and a high forecast of 44.6 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is TKD's stock price target?
Price Target
33.96
EUR
According to Wall Street analysts, the average 1-year price target for TKD is 33.96 EUR with a low forecast of 28.24 EUR and a high forecast of 44.6 EUR.
What is the Revenue forecast for Takeda Pharmaceutical Co Ltd?
Projected CAGR
3%
Over the last 13 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 3 years is 3%.
What is the Gross Profit forecast for Takeda Pharmaceutical Co Ltd?
Projected CAGR
2%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 8%. The projected CAGR for the next 2 years is 2%.
What is the Operating Income forecast for Takeda Pharmaceutical Co Ltd?
Projected CAGR
-24%
Over the last 13 years, the compound annual growth rate for Operating Income has been 14%. The projected CAGR for the next 1 year is -24%.
